iBio receives notice from NYSE that company is below listing standards As previously announced, the company submitted, and the Exchange subsequently accepted a plan of compliance which is intended to restore the company's compliance with the Exchange's continued listing criteria set forth in Section 1003(a)(iii) of the NYSE MKT Company Guide. Due to the higher stockholder's equity requirement contained in Section 1003(a)(iii), the Company is not required to submit an additional plan of compliance in connection with the deficiency noticed in the Exchange's most recent correspondence.
News For IBIO From The Last 14 Days
Check below for free stories on IBIO the last two weeks.
Subscribe for More Information